Literature DB >> 27058686

The promise and challenge of epitope-focused vaccines.

Jon Oscherwitz1,2.   

Abstract

Traditional vaccination with whole pathogens or pathogen-derived subunits has completely eliminated diseases like smallpox, and has greatly limited the incidence, morbidity and mortality associated with many other infectious diseases. Unfortunately, a large burden of infectious disease remains that may be preventable through vaccination. For many of these, more focused and innovative approaches may be essential for the development of effective vaccines.

Entities:  

Keywords:  antibody; epitope-focused; immunization; peptide; vaccine

Mesh:

Substances:

Year:  2016        PMID: 27058686      PMCID: PMC4994726          DOI: 10.1080/21645515.2016.1160977

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  35 in total

1.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

Authors:  P Panina-Bordignon; A Tan; A Termijtelen; S Demotz; G Corradin; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

2.  Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.

Authors:  Jeanne H Schickli; David C Whitacre; Roderick S Tang; Jasmine Kaur; Heather Lawlor; Cory J Peters; Joyce E Jones; Darrell L Peterson; Michael P McCarthy; Gary Van Nest; David R Milich
Journal:  J Clin Invest       Date:  2015-03-09       Impact factor: 14.808

3.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Authors:  H W Kim; J G Canchola; C D Brandt; G Pyles; R M Chanock; K Jensen; R H Parrott
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

4.  Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.

Authors:  J M Calvo-Calle; J Hammer; F Sinigaglia; P Clavijo; Z R Moya-Castro; E H Nardin
Journal:  J Immunol       Date:  1997-08-01       Impact factor: 5.422

Review 5.  Cancer immunoprevention.

Authors:  Olivera J Finn; Pamela L Beatty
Journal:  Curr Opin Immunol       Date:  2016-01-19       Impact factor: 7.486

Review 6.  Conjugate vaccines.

Authors:  Stephen Lockhart
Journal:  Expert Rev Vaccines       Date:  2003-10       Impact factor: 5.217

Review 7.  Reverse vaccinology: developing vaccines in the era of genomics.

Authors:  Alessandro Sette; Rino Rappuoli
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

8.  Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.

Authors:  Jon Oscherwitz; Kemp B Cease
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

Review 9.  The great balancing act: regulation and fate of antiviral T-cell interactions.

Authors:  E Ashley Moseman; Dorian B McGavern
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

Review 10.  Vaccine-induced enhancement of viral infections.

Authors:  W Huisman; B E E Martina; G F Rimmelzwaan; R A Gruters; A D M E Osterhaus
Journal:  Vaccine       Date:  2008-11-18       Impact factor: 3.641

View more
  16 in total

Review 1.  Toward rational vaccine engineering.

Authors:  Yashavantha L Vishweshwaraiah; Nikolay V Dokholyan
Journal:  Adv Drug Deliv Rev       Date:  2022-02-09       Impact factor: 15.470

Review 2.  Moving beyond Titers.

Authors:  Benjamin D Brooks; Alexander Beland; Gabriel Aguero; Nicholas Taylor; Francina D Towne
Journal:  Vaccines (Basel)       Date:  2022-04-26

3.  RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition.

Authors:  Carolina Nunes; Lisa Depestel; Liselot Mus; Kaylee M Keller; Louis Delhaye; Amber Louwagie; Muhammad Rishfi; Alex Whale; Neesha Kara; Simon R Andrews; Filemon Dela Cruz; Daoqi You; Armaan Siddiquee; Camila Takeno Cologna; Sam De Craemer; Emmy Dolman; Christoph Bartenhagen; Fanny De Vloed; Ellen Sanders; Aline Eggermont; Sarah-Lee Bekaert; Wouter Van Loocke; Jan Willem Bek; Givani Dewyn; Siebe Loontiens; Gert Van Isterdael; Bieke Decaesteker; Laurentijn Tilleman; Filip Van Nieuwerburgh; Vanessa Vermeirssen; Christophe Van Neste; Bart Ghesquiere; Steven Goossens; Sven Eyckerman; Katleen De Preter; Matthias Fischer; Jon Houseley; Jan Molenaar; Bram De Wilde; Stephen S Roberts; Kaat Durinck; Frank Speleman
Journal:  Sci Adv       Date:  2022-07-13       Impact factor: 14.957

Review 4.  Rift Valley fever: biology and epidemiology.

Authors:  Daniel Wright; Jeroen Kortekaas; Thomas A Bowden; George M Warimwe
Journal:  J Gen Virol       Date:  2019-07-16       Impact factor: 5.141

5.  Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between Plasmodium vivax PvDBP and Plasmodium falciparum VAR2CSA.

Authors:  Catherine J Mitran; Angie Mena; Sedami Gnidehou; Shanna Banman; Eliana Arango; Barbara A S Lima; Hazel Lugo; Aravindhan Ganesan; Ali Salanti; Anthony K Mbonye; Francis Ntumngia; Khaled Barakat; John H Adams; Flora S Kano; Luzia H Carvalho; Amanda E Maestre; Michael F Good; Stephanie K Yanow
Journal:  mBio       Date:  2019-10-08       Impact factor: 7.867

6.  Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.

Authors:  Theresa B Gallagher; Gabriela Mellado-Sanchez; Ana L Jorgensen; Stephen Moore; James P Nataro; Marcela F Pasetti; Les W Baillie
Journal:  PLoS Negl Trop Dis       Date:  2019-08-20

7.  Towards the first multi-epitope recombinant vaccine against Crimean-Congo hemorrhagic fever virus: A computer-aided vaccine design approach.

Authors:  Mokhtar Nosrati; Mandana Behbahani; Hassan Mohabatkar
Journal:  J Biomed Inform       Date:  2019-03-27       Impact factor: 6.317

Review 8.  Inside the story about the research and development of COVID-19 vaccines.

Authors:  Shrina P Patel; Gayatri S Patel; Jalpa V Suthar
Journal:  Clin Exp Vaccine Res       Date:  2021-05-31

9.  Structural patterns of selection and diversity for Plasmodium vivax antigens DBP and AMA1.

Authors:  Andrew J Guy; Vashti Irani; Jack S Richards; Paul A Ramsland
Journal:  Malar J       Date:  2018-05-02       Impact factor: 2.979

10.  Epitope-Based Peptide Vaccine against Glycoprotein G of Nipah Henipavirus Using Immunoinformatics Approaches.

Authors:  Arwa A Mohammed; Shaza W Shantier; Mujahed I Mustafa; Hind K Osman; Hashim E Elmansi; Isam-Aldin A Osman; Rawan A Mohammed; Fatima A Abdelrhman; Mihad E Elnnewery; Einas M Yousif; Marwa M Mustafa; Nafisa M Elfadol; Alaa I Abdalla; Eiman Mahmoud; Ahmed A Yagaub; Yassir A Ahmed; Mohamed A Hassan
Journal:  J Immunol Res       Date:  2020-04-22       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.